Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 3Phase 3 3Phase 1 3Phase EARLY_PHASE1 2Phase 2/3 1

Status

Recruiting 1Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Plasma cell 1Myeloid 1Genitourinary 1

Conditions

Thrombocythemia, Essential 1Stomach Neoplasms 1Smoldering Multiple Myeloma 1Rectal Neoplasms 1Prostatic Neoplasms 1Primary Myelofibrosis 1Polycythemia Vera 1Myelodysplastic Syndromes 1Multiple Myeloma 1Monoclonal Gammopathy of Undetermined Significance 1Gastritis, Atrophic 1

Interventions

pembrolizumab 519Specimen Handling 382Carboplatin 374Magnetic Resonance Spectroscopy 337Cisplatin 328Nivolumab 309Cyclophosphamide 296Radiotherapy 256Paclitaxel 256Gemcitabine 235Biopsy 234Bevacizumab 213Dexamethasone 169durvalumab 166Oxaliplatin 162Rituximab 158Capecitabine 157Fluorouracil 148venetoclax 147Docetaxel 146Etoposide 141atezolizumab 140Drug Therapy 140Doxorubicin 134Ipilimumab 130Prednisone 120Lenalidomide 119Radiosurgery 118Leucovorin 112fludarabine 108

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Curcumin × 1 year × Clear all
NCT04731844 2026-05-12

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

University of Rochester

Phase 2 Completed
30 enrolled 13 charts
GenitourinaryPlasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, Prostatic Neoplasms

NCT02782949 2026-04-21

Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia

National Cancer Institute (NCI)

Phase 2 Active not recruiting
50 enrolled 10 charts
Gastrointestinal

Gastritis, Atrophic, Stomach Neoplasms

NCT06063486 2026-03-27

Curcumin to Improve Inflammation and Symptoms in Patients With Clonal Cytopenia of Undetermined Significance, Low Risk Myelodysplastic Syndrome, and Myeloproliferative Neoplasms

University of Southern California

Phase 2 Recruiting
30 enrolled
Myeloid

Myelodysplastic Syndromes, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT07248020 2025-11-25

BCMRECRAD

Chang Gung Memorial Hospital

Phase 2 Not yet recruiting
72 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡